The MHRA has published new regulatory guidance clarifying how microbiome-based medicinal products can progress towards UK licensing. Teva Pharmaceuticals...
Lire la suiteNHS England has recommended routine commissioning of delayed-release mercaptamine bitartrate for eligible patients aged one year and above with...
Lire la suiteBeOne Medicines has secured a UK Innovation Passport for investigational bispecific antibody BGB-B2033 in advanced or metastatic hepatocellular carcinoma....
Lire la suiteAtsena Therapeutics has secured European orphan designation for two gene therapy candidates targeting rare inherited retinal diseases. Infinitopes has...
Lire la suiteLundbeck has secured FDA Fast Track designation for Lu AH69593, an oral orexin 2 receptor agonist being developed for...
Lire la suiteNICE has issued final draft guidance recommending Bayer’s finerenone for adults with symptomatic chronic heart failure and a left...
Lire la suite